ArticleFrontiers in medicine2026
Multisystem laboratory changes before and after blood purification in acute pancreatitis: a real-world descriptive analysis of 141 cases.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute pancreatitis (AP) is a dynamic, multisystem disorder. Blood purification (BP) is increasingly utilized in severe or hypertriglyceridemia-associated AP, yet the overall patterns and cross-dimensional heterogeneity of post-BP laboratory shifts remain poorly characterized. Objective: To map the patterns, magnitudes, cross-system correlations, and patient-level heterogeneity of paired laboratory parameter changes observed before and after BP in AP patients using real-world data, strictly without inferring causal efficacy. Methods: This retrospective observational study analyzed 141 consecutive AP patients receiving BP (hemoperfusion, plasma exchange, or combined). Paired laboratory indicators across seven biological domains were compared. An exploratory multisystem laboratory change score (0∼6) was constructed to evaluate directional consistency. Rule-based stratification was applied to examine change patterns alongside change-magnitude ranking and subgroup analyses. Results: Most laboratory indicators exhibited post-treatment reductions. The largest relative median decreases occurred in IL-6 (-86.79%), serum amylase (-86.67%), and triglycerides (-86.23%). The mean multisystem change score was 4.24 ± 1.34; concurrent directional shifts occurred across ≥3 domains in 87.94% of patients and ≥4 domains in 70.92%. Exploratory stratification identified subgroups exhibiting greater, intermediate, or smaller multidimensional shifts. Correlation analysis demonstrated strong intra-domain synchrony between renal parameters ( Conclusions: Patients with AP showed marked, heterogeneous pre- to post-BP multidimensional laboratory shifts. Lacking a contemporaneous control group, these observational changes cannot be causally attributed to BP and reflect the combined influence of natural disease evolution, fluid resuscitation, and concurrent supportive care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.